We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
TotalEnergies
TTE
$195B
| $375M | 0.53% |
6,044,422
-1,024,739
| -14% | -$58.5M |
|
52
Novartis
NVS
$297B
| $374M | 0.52% |
4,127,082
+2,498,355
| +153% | +$210M |
|
53
Valero Energy
VLO
$90.6B
| $370M | 0.52% |
2,915,692
-215,709
| -7% | -$27.1M |
|
54
Thermo Fisher Scientific
TMO
$220B
| $362M | 0.51% |
657,303
+134,314
| +26% | +$71.2M |
|
55
Synopsys
SNPS
$79.5B
| $362M | 0.51% |
1,132,920
+109,032
| +11% | +$34.1M |
|
56
PayPal
PYPL
$50.1B
| $360M | 0.5% |
5,050,345
+1,600,539
| +46% | +$128M |
|
57
Marathon Petroleum
MPC
$88.9B
| $358M | 0.5% |
3,076,540
-1,388,068
| -31% | -$158M |
|
58
Hewlett Packard
HPE
$73.1B
| $345M | 0.48% |
21,641,979
+8,116,822
| +60% | +$120M |
|
59
Cadence Design Systems
CDNS
$92.6B
| $340M | 0.48% |
2,114,613
+236,047
| +13% | +$37.7M |
|
60
iShares MSCI Taiwan ETF
EWT
$11B
| $338M | 0.47% |
8,420,186
+1,084,657
| +15% | +$48.3M |
|
61
FedEx
FDX
$76.8B
| $338M | 0.47% |
1,951,974
+500,361
| +34% | +$83.2M |
|
62
Stellantis
STLA
$21.1B
| $333M | 0.47% |
23,426,375
-5,604,444
| -19% | -$78M |
|
63
McDonald's
MCD
$193B
| $332M | 0.46% |
1,259,667
-301,130
| -19% | -$79.4M |
|
64
Equinor
EQNR
$97.7B
| $325M | 0.45% |
9,078,333
-875,114
| -9% | -$31.4M |
|
65
Cisco
CSCO
$489B
| $316M | 0.44% |
6,631,150
-1,475,220
| -18% | -$67.1M |
|
66
ASML
ASML
$672B
| $316M | 0.44% |
577,509
+103,208
| +22% | +$54.1M |
|
|
HOLX
67
DELISTED
Hologic
HOLX
| $310M | 0.43% |
4,144,739
+181,720
| +5% | +$12.9M |
|
68
Yum! Brands
YUM
$40B
| $305M | 0.43% |
2,383,385
+749,072
| +46% | +$90.7M |
|
69
Cardinal Health
CAH
$55.6B
| $298M | 0.42% |
3,876,715
+1,327,772
| +52% | +$101M |
|
70
Stryker
SYK
$132B
| $291M | 0.41% |
1,191,304
-33,522
| -3% | -$7.61M |
|
71
Wells Fargo
WFC
$265B
| $290M | 0.41% |
7,033,805
+1,053,304
| +18% | +$46.6M |
|
72
Centene
CNC
$32.9B
| $288M | 0.4% |
3,513,933
+315,984
| +10% | +$25.8M |
|
|
DFS
73
DELISTED
Discover Financial Services
DFS
| $269M | 0.38% |
2,749,914
+364,988
| +15% | +$36.7M |
|
74
United Rentals
URI
$71B
| $268M | 0.38% |
755,063
+126,880
| +20% | +$41.7M |
|
|
75
AstraZeneca
AZN
$251B
| $266M | 0.37% |
1,959,272
+1,873,344
| +2,180% | +$235M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.